D

G

DES GUETZ , Gaëtan

Last name: DES GUETZ

First name: Gaëtan

January 1, 2019 (v1)

Journal article

Metadata-only

Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer

Bennouna, Jaafar Hiret, Sandrine Bertaut, Aurélie

Importance:Second-line treatment with chemotherapy plus bevacizumab or cetuximab is a valid option for metastatic colorectal cancer.Objective:To evaluate the progression-free survival (PFS) rate at 4 months with chemotherapy plus bevacizumab vs cetuximab for patients with progression of metastatic colorectal cancer after bevacizumab plus...

Uploaded on: December 4, 2022